Drug profile · INN
miltefosine
IMPAVIDO
miltefosine (IMPAVIDO) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — miltefosine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
miltefosine (IMPAVIDO) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN miltefosine
Brand IMPAVIDO
Mechanism Unknown
Route ORAL
Formulation CAPSULE
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is miltefosine?
miltefosine (IMPAVIDO) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for miltefosine?
IMPAVIDO is a marketed brand name for miltefosine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of miltefosine?
miltefosine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.